BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29723356)

  • 21. Twice weekly 5 mg betamethasone oral pulse therapy in the treatment of alopecia areata.
    Agarwal A; Nath J; Barua KN
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1375-6. PubMed ID: 17062087
    [No Abstract]   [Full Text] [Related]  

  • 22. ILK Index and Regrowth in Alopecia Areata.
    Stallings AM; Velez MW; Fiessinger LA; Piliang MP; Mesinkovska NA; Kyei A; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):47-9. PubMed ID: 26551947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose intravenous corticosteroid pulse therapy in alopecia areata: own experience compared with the literature.
    Luggen P; Hunziker T
    J Dtsch Dermatol Ges; 2008 May; 6(5):375-8. PubMed ID: 18205838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical tretinoin as an adjunctive therapy with intralesional triamcinolone acetonide for alopecia areata. Clinical experience in northern Saudi Arabia.
    Kubeyinje EP; C'Mathur M
    Int J Dermatol; 1997 Apr; 36(4):320. PubMed ID: 9169343
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of different concentrations of intralesional triamcinolone acetonide for alopecia areata: A systematic review and meta-analysis.
    Yee BE; Tong Y; Goldenberg A; Hata T
    J Am Acad Dermatol; 2020 Apr; 82(4):1018-1021. PubMed ID: 31843657
    [No Abstract]   [Full Text] [Related]  

  • 26. Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata.
    Ganjoo S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2013; 79(3):408-17. PubMed ID: 23619446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs.
    Kubeyinje EP
    East Afr Med J; 1994 Oct; 71(10):674-5. PubMed ID: 7821250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A Critically Appraised Topic.
    Kassim JM; Shipman AR; Szczecinska W; Siah TW; Lam M; Chalmers J; Macbeth AE
    Br J Dermatol; 2014 Apr; 170(4):766-71. PubMed ID: 24484438
    [No Abstract]   [Full Text] [Related]  

  • 29. [THE PROBLEM OF SIDE-EFFECTS IN ADRENAL CORTEX HORMONE TREATMENT OF SKIN DISEASES].
    NOHARA N; TSUKINOKI K; TODA M
    Nisshin Igaku Jpn J Med Prog; 1963 Apr; 50():225-43. PubMed ID: 14062702
    [No Abstract]   [Full Text] [Related]  

  • 30. [Alopecia areata].
    von Felbert V; Merk HF
    Hautarzt; 2013 Nov; 64(11):806-9. PubMed ID: 24177663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alopecia areata: current therapy.
    Fiedler VC
    J Invest Dermatol; 1991 May; 96(5):69S-70S. PubMed ID: 2022876
    [No Abstract]   [Full Text] [Related]  

  • 32. Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study.
    Chu TW; AlJasser M; Alharbi A; Abahussein O; McElwee K; Shapiro J
    J Am Acad Dermatol; 2015 Aug; 73(2):338-40. PubMed ID: 26183987
    [No Abstract]   [Full Text] [Related]  

  • 33. A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata.
    Bhat S; Handa S; De D
    Indian J Dermatol Venereol Leprol; 2021; 87(1):42-48. PubMed ID: 33580923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Less painful and effective intralesional injection method for lichen simplex chronicus.
    Jung HM; Eun SH; Lee JH; Kim GM; Bae JM
    J Am Acad Dermatol; 2018 Dec; 79(6):e105-e106. PubMed ID: 30025827
    [No Abstract]   [Full Text] [Related]  

  • 35. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector.
    Abell E; Munro DD
    Br J Dermatol; 1973 Jan; 88(1):55-9. PubMed ID: 4686543
    [No Abstract]   [Full Text] [Related]  

  • 36. Contact immunotherapy-resistant alopecia areata totalis/universalis reactive to topical corticosteroid.
    Inui S; Itami S
    J Dermatol; 2015 Sep; 42(9):937-9. PubMed ID: 26010699
    [No Abstract]   [Full Text] [Related]  

  • 37. Alopecia areata: an update.
    Seetharam KA
    Indian J Dermatol Venereol Leprol; 2013; 79(5):563-75. PubMed ID: 23974575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful hair transplant of eyebrow alopecia areata.
    Barankin B; Taher M; Wasel N
    J Cutan Med Surg; 2005 Aug; 9(4):162-4. PubMed ID: 16502201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical and intralesional therapies for alopecia areata.
    Alkhalifah A
    Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: a double-blind randomized controlled study.
    Hajheydari Z; Jamshidi M; Akbari J; Mohammadpour R
    Indian J Dermatol Venereol Leprol; 2007; 73(1):29-32. PubMed ID: 17314444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.